insys

  1. Ron Strider

    This Marijuana Stock Could Be The Biggest Comeback Story Of 2018

    Insys Therapeutics is one of the most hated biotech stocks on the market today. That's the case, at least, if you use short interest as a proxy for how much investors hate a given stock: A whopping 40% of Insys stock's float is sold short. There is a laundry list of reasons why Insys has...
  2. Ron Strider

    This U.S. Marijuana Stock Is Arguably The Best On The Market -- And It's Dirt Cheap

    What's the best U.S. marijuana stock on the market right now? Including only the U.S. in the question excludes several of the top candidates, such as U.K.-based GW Pharmaceuticals and the leading Canadian medical-marijuana suppliers. The word "best" is subjective, of course, but in my view...
  3. Ron Strider

    Why This Marijuana Stock Crashed 18.5% In August

    A lawsuit tied to the marketing of its fentanyl opioid spray caused Insys Therapeutics' shares to tumble last month. What happened Arizona's attorney general is suing Insys Therapeutics over its marketing of the fentanyl opioid spray, Subsys, and that news caused the company's shares to...
  4. Ron Strider

    This Struggling Marijuana Stock Finally Launched Its Highly Anticipated Drug

    If you look around, chances are you won't find many marijuana stocks struggling. In fact, over the trailing one-year period, 12 out of 13 pot stocks with a market cap above $200 million had risen, with a majority up by at least 100%! Marijuana stocks are mostly budding A pretty steady...
  5. Ron Strider

    This Marijuana Stock Skyrocketed Last Week, While 3 Others Plunged

    When it comes to the market's top-performing stocks, you'd have a hard time topping marijuana stocks over the trailing year. A majority of pot stocks over the past 12 months have at least doubled in value, with some even tripling or quadrupling. For added context, the stock market tends to...
  6. Ron Strider

    Marijuana Legalization Could Hurt These Marijuana Stocks

    Support of marijuana legalization is at an all-time high. States across the country have legalized marijuana, either for medical use, recreational use, or both. You might think that every marijuana stock would benefit from these trends. But that's not the case. One company with a cannabinoid...
  7. Ron Strider

    The Only Marijuana Stock To Rocket Higher By Double-Digit Percentage Last Week

    Chances are that if investors took a good look around, they'd struggle to find an industry growing as fast as the legal weed industry, which is what makes marijuana stocks such an attractive lure. According to the "Marijuana Business Factbook 2017," a recently released report from Marijuana...
  8. Katelyn Baker

    AZ: Feds Bust Former Execs From Drug Firm That Bankrolled Anti-Marijuana Campaign

    Remember how prosecutors in Arizona took big money the drug company Insys Therapeutics to defeat the initiative that would have legalized small amounts of marijuana? Well, prosecutors in Massachusetts busted former executives of that same company on charges of racketeering, with allegations...
  9. Katelyn Baker

    AZ: Pro-Marijuana Campaign Questions Chandler Medical Firm's Opposition

    A Chandler firm that could lose business from legalized marijuana is now the largest contributor to a campaign to stop that from happening here. Reports filed with the secretary of state's office show Insys Therapeutics, whose sole product is an opiate spray to treat pain for cancer patients...
  10. Katelyn Baker

    AZ: Pro-Marijuana Campaign Questions Chandler Medical Firm's Opposition

    A Chandler firm that could lose business from legalized marijuana is now the largest contributor to a campaign to stop that from happening here. Reports filed with the secretary of state's office show Insys Therapeutics, whose sole product is an opiate spray to treat pain for cancer patients...
  11. Katelyn Baker

    Insys Fighting Cannabis Legalization - It Would Limit Commercial Success Of Its Drugs

    An Arizona-based pharmaceutical company is fighting weed legalization, due at least in part to fears that it will hurt their business. Insys Therapeutics Inc, gave $500,000 to Arizonans for Responsible Drug Policy, a prominent anti-marijuana legalization group, becoming the group's single...
  12. Katelyn Baker

    INSYS Therapeutics Jumps On FDA Approval Of Cannabis-Based Drug

    Shares of INSYS Therapeutics Inc are trading 15 percent higher this morning, after the company announced that its cannabis-based medication has been approved by the United States Food and Drug Administration (FDA). The innovative drug, which is called Syndros, is an orally taken liquid form of a...
  13. Katelyn Baker

    INSYS Therapeutics Jumps On FDA Approval Of Cannabis-Based Drug

    Shares of INSYS Therapeutics Inc are trading 15 percent higher this morning, after the company announced that its cannabis-based medication has been approved by the United States Food and Drug Administration (FDA). The innovative drug, which is called Syndros, is an orally taken liquid form of a...
  14. Katelyn Baker

    Insys Therapeutics Is Hoping Syndros Is Its Blockbuster Marijuana Ticket

    Summary Insys has a PDUFA for Syndros scheduled for July 1. The drug is a sublingual spray reformulation of its currently marketed Marinol. An approval is a potential double-digit upside catalyst for the company. There are risks, and the company has a chequered past, the fallout...
Back
Top Bottom